Active Penny Stocks in the News
PennyTrader.com presents a range of the hottest penny stocks on the OTC and OTCBB market today. In addition to daily hot stock alerts, PennyTrader.com‘s new penny stock alert service is fast becoming the premier stock alert list to be on.
Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/
Electric Car Company, Inc. (OTCBB: ELCR) reached up 42.86% in morning trading to $.001 with 58M shares traded. Electric Car Company, Inc. (OTCBB:ELCR - News), a vehicle conversion Company that specializes in electric conversions and manufacturing for the Livery and Fleet Markets, announced today that it has been awarded a 12 month contract with Don Brown Bus Sales, Inc. The Contract, valued at $750,000.00, calls for Electric Car Company, (ECC), to convert up to twenty-five (25) Federal Coach bus chassis into Imperial Coach limobuses. The Company plans to deliver the first two buses by mid-August of this year.
For detailed quote and full article http://www.pennytrader.com/quotes/ELCR.php
SNM Global Holdings (OTC: SNMN) was up 13.33% in morning trading to $.0017 with 9M shares traded. SNM Global Holdings (SNM Global) is a technology holding and development company that invests in, acquires, and develops Intellectual Property Assets and Operations in the Clean/Alternative Energy, Biotech, Water and Better Health & Living sectors adapted specifically for the emerging global markets. SNM Global Holdings (Pinksheets: SNMN - News) announced the signing of a Letter of Intent (LOI) with EQ-ip Equities (EQ-ip), a private technology and licensing holding company, to acquire, develop, distribute, and commercialize certain technologies from its portfolio.
For detailed quote and full article http://www.pennytrader.com/quotes/SNMN.php
Curis, Inc. (NASDAQ: CRIS) was up 10.34% in morning trading to $1.60 with 120K shares traded. Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer. Curis, Inc. (NASDAQ: CRIS - News) announced today that its licensee Debiopharm S.A. (“Debiopharm”) has treated the fifth patient in its ongoing Phase I clinical trial for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of the August 2009 license agreement between Curis and Debiopharm, Curis will receive a $3 million milestone payment from Debiopharm for the achievement of this development objective.
For detailed quote and full article http://www.pennytrader.com/quotes/CRIS.php
Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks
in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
For complete disclosure information go to http://www.pennytrader.com/disclosure/
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to http://www.pennytrader.com/disclaimer/
